Detalles de la búsqueda
1.
Severe Immune-Related Enteritis after In Utero Exposure to Pembrolizumab.
N Engl J Med
; 389(19): 1790-1796, 2023 Nov 09.
Artículo
Inglés
| MEDLINE | ID: mdl-37937778
2.
Analytical Validation of a Volumetric Absorptive Microsampling Method for Therapeutic Drug Monitoring of the Oral Targeted Anticancer Agents, Abiraterone, Alectinib, Cabozantinib, Imatinib, Olaparib, and Sunitinib, and Metabolites.
Ther Drug Monit
; 2024 Jan 30.
Artículo
Inglés
| MEDLINE | ID: mdl-38321598
3.
Cortisol as Biomarker for CYP17-Inhibition is Associated with Therapy Outcome of Abiraterone Acetate.
Pharm Res
; 40(12): 3001-3010, 2023 Dec.
Artículo
Inglés
| MEDLINE | ID: mdl-37821768
4.
A simple extemporaneous oral suspension of aprepitant yields sufficient pharmacokinetic exposure in children.
J Oncol Pharm Pract
; 29(4): 899-904, 2023 Jun.
Artículo
Inglés
| MEDLINE | ID: mdl-35377726
5.
Bioanalytical methods for pharmacokinetic studies of antileishmanial drugs.
Biomed Chromatogr
; 37(7): e5519, 2023 Jul.
Artículo
Inglés
| MEDLINE | ID: mdl-36208186
6.
ABCB1 and ABCG2 limit brain penetration and, together with CYP3A4, total plasma exposure of abemaciclib and its active metabolites.
Pharmacol Res
; 178: 105954, 2022 04.
Artículo
Inglés
| MEDLINE | ID: mdl-34700018
7.
Everolimus Concentration in Saliva to Predict Stomatitis: A Feasibility Study in Patients with Cancer.
Ther Drug Monit
; 44(4): 520-526, 2022 08 01.
Artículo
Inglés
| MEDLINE | ID: mdl-35094002
8.
Overestimation of the effect of (fos)aprepitant on intravenous dexamethasone pharmacokinetics requires adaptation of the guidelines for children with chemotherapy-induced nausea and vomiting.
Support Care Cancer
; 30(12): 9991-9999, 2022 Dec.
Artículo
Inglés
| MEDLINE | ID: mdl-36287279
9.
Phase I Study of Afatinib and Selumetinib in Patients with KRAS-Mutated Colorectal, Non-Small Cell Lung, and Pancreatic Cancer.
Oncologist
; 26(4): 290-e545, 2021 04.
Artículo
Inglés
| MEDLINE | ID: mdl-33296125
10.
P-Glycoprotein (ABCB1/MDR1) Controls Brain Penetration and Intestinal Disposition of the PARP1/2 Inhibitor Niraparib.
Mol Pharm
; 18(12): 4371-4384, 2021 12 06.
Artículo
Inglés
| MEDLINE | ID: mdl-34730366
11.
Cost-Effectiveness Assessment of Monitoring Abiraterone Levels in Metastatic Castration-Resistant Prostate Cancer Patients.
Value Health
; 24(1): 121-128, 2021 01.
Artículo
Inglés
| MEDLINE | ID: mdl-33431146
12.
P-glycoprotein (MDR1/ABCB1) controls brain accumulation and intestinal disposition of the novel TGF-ß signaling pathway inhibitor galunisertib.
Int J Cancer
; 146(6): 1631-1642, 2020 03 15.
Artículo
Inglés
| MEDLINE | ID: mdl-31304590
13.
Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer.
Br J Cancer
; 122(8): 1166-1174, 2020 04.
Artículo
Inglés
| MEDLINE | ID: mdl-32147669
14.
Mass balance and metabolite profiling of 14C-guadecitabine in patients with advanced cancer.
Invest New Drugs
; 38(4): 1085-1095, 2020 08.
Artículo
Inglés
| MEDLINE | ID: mdl-31605293
15.
Quantitative LC-MS/MS analysis of 5-hydroxymethyl-2'-deoxyuridine to monitor the biological activity of J-binding protein.
Anal Biochem
; 610: 113930, 2020 12 01.
Artículo
Inglés
| MEDLINE | ID: mdl-32866463
16.
Phase I pharmacological study of continuous chronomodulated capecitabine treatment.
Pharm Res
; 37(5): 89, 2020 May 07.
Artículo
Inglés
| MEDLINE | ID: mdl-32382808
17.
Determination of the absolute bioavailability of oral imatinib using a stable isotopically labeled intravenous imatinib-d8 microdose.
Eur J Clin Pharmacol
; 76(8): 1075-1082, 2020 Aug.
Artículo
Inglés
| MEDLINE | ID: mdl-32430518
18.
Vorinostat in patients with resistant BRAFV600E mutated advanced melanoma: a proof of concept study.
Future Oncol
; 16(11): 619-629, 2020 Apr.
Artículo
Inglés
| MEDLINE | ID: mdl-32125175
19.
Bioanalytical LC-MS/MS validation of therapeutic drug monitoring assays in oncology.
Biomed Chromatogr
; 34(1): e4623, 2020 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-31215049
20.
A review of the bioanalytical methods for the quantitative determination of capecitabine and its metabolites in biological matrices.
Biomed Chromatogr
; 34(1): e4732, 2020 Jan.
Artículo
Inglés
| MEDLINE | ID: mdl-31691313